1. Signaling Pathways
  2. Vitamin D Related/Nuclear Receptor
  3. Estrogen Receptor/ERR
  4. Estrogen Receptor/ERR Inhibitors

Estrogen Receptor/ERR Inhibitors

Estrogen receptor

ERα

ERβ

ERRα

ERRβ

ERRγ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Estrogen Receptor/ERR Degraders, Inhibitors, Agonists, Antagonists, Activators, Modulators & Chemicals
Product Name Estrogen receptor ERα ERβ ERRα ERRβ ERRγ Purity
Tamoxifen
Estrogen receptor
          99.92%
4-Hydroxytamoxifen
Estrogen receptor, IC50: 3.3 nM
          99.96%
Kaempferol  
ERα
        99.92%
Tamoxifen Citrate
Estrogen receptor
          99.93%
Propyl pyrazole triol  
ERα
        99.11%
Saikosaponin D    
ERβ
      98.76%
XCT790      
ERRα, IC50: 0.37 μM
    99.54%
DPN    
ERβ, EC50: 0.85 nM
      99.66%
(Z)-Ligustilide  
ERα
        99.11%
GSK5182          
ERRγ, IC50: 79 nM
99.85%
Giredestrant
ER
          99.52%
(E/Z)-4-Hydroxytamoxifen
Estrogen receptor
          99.60%
Raloxifene
Estrogen receptor
          99.62%
SLU-PP-332      
ERRα, EC50: 98 nM
ERRβ, EC50: 230 nM
ERRγ, EC50: 430 nM
99.82%
Tamoxifen (Standard)
Estrogen receptor
          99.76%
DY131        
ERRβ
ERRγ
99.72%
Amcenestrant  
ERα, EC50: 0.2 nM
        99.79%
Prinaberel  
hERα, IC50: 1200 nM
mouse ERα, IC50: 750 nM
rat ERα, IC50: 620 nM
hERβ, IC50: 5.4 nM
rat ERβ, IC50: 3.1 nM
mouse ERβ, IC50: 3.7 nM
      98.05%
MPP dihydrochloride  
ERα
ERβ
      99.06%
Smurf1-IN-A01  
ERα
        99.81%
DS45500853      
ERRα
    98.15%
ERRα antagonist-1      
ERRα
    99.71%
Endoxifen  
ERα
        99.42%
GNE-149  
ERα, IC50: 0.053 nM
        99.66%
WAY-200070  
ERα, IC50: 155 nM
ERβ, IC50: 2.3 nM
      99.73%
MPP hydrochloride  
ERα
ERβ
      99.28%
Palazestrant
17b-estradiol (E2), IC50: 6.4 nM
          98.96%
Zearalanone
Estrogen receptor
          99.96%
Hexestrol  
ERα, Ki: 0.06 nM
ERβ, Ki: 0.06 nM
      99.89%
PROTAC ERRα Degrader-3      
ERRα
    98.82%
PROTAC ERRα ligand 1      
ERRα, IC50: 0.04 μM
 
ERRγ, IC50: 2.8 μM
99.47%
Erteberel    
ERβ, Ki: 1.54 nM
ERβ, EC50: 3.61 nM
      99.87%
DS20362725      
ERRα
    99.34%
H3B-5942  
ERαY537S, Ki: 0.41 nM
ERαWT, Ki: 1 nM
        99.73%
(E)-4-Hydroxytamoxifen
Estrogen receptor
          98.27%
ERRγ agonist-1          
ERRγ
98.70%
FLTX1  
ERα, IC50: 87.5 nM
        99.78%
OP-1074  
ERα
ERβ
      99.77%
Ferutinin  
ERα, IC50: 33.1 nM
ERβ, IC50: 180.5 nM
      99.23%
PROTAC ERα Degrader-2  
ERα
        98.92%
Acolbifene  
ERα, IC50: 2 nM (E2-induced transcriptional activity)
ERβ, IC50: 0.4 nM (E2-induced transcriptional activity)
      99.52%
Acolbifene hydrochloride  
ERα, IC50: 2 nM (E2-induced transcriptional activity)
ERβ, IC50: 0.4 nM (E2-induced transcriptional activity)
      99.00%
Estrogen receptor β antagonist 2  
ERα, IC50: 109.10 μM
ERβ, IC50: 0.63 μM
      98.39%
PROTAC ER Degrader-4
ER
          98.22%
Tamoxifen-d5
Estrogen receptor
          99.99%
ERα degrader-2  
ERα, IC50: 4.6 nM
        99.71%
Y134  
ERα, Ki: 0.09 nM
ERβ, Ki: 11.31 nM
      98.34%
AC-186  
ERα, EC50: 5000 nM
ERβ, EC50: 6 nM
      99.61%
PROTAC ERα Degrader-6  
ERα, DC50: 0.12 μM
       
PROTAC ERRα Degrader-1      
ERRα
   
PROTAC ERα Degrader-4  
ERα, Ki: 5.08 μM
ERβ, Ki: 26.20 μM
     
(R,R)-THC  
ERα, Ki: 9.0 nM
ERβ, Ki: 3.6 nM
      ≥99.0%
LY117018
Estrogen receptor
          99.47%
2-Hydroxyestrone
Estrogen receptor
          98.57%
ERRγ inverse agonist 1  
ERα, IC50: 1.240 μM
   
ERRβ, IC50: 1.330 μM
ERRγ, IC50: 0.040 μM
Giredestrant tartrate
Estrogen receptor
         
ERα degrader 5  
ERα, EC50: 1.1 nM
ERα, IC50: 0.9 nM
ERβ, IC50: 2.3 nM
     
4',2-Dihydroxy-4,6-dimethoxydihydrochalcone
Estrogen receptor
         
ERα antagonist 1  
ERα
       
ERα degrader 11  
ERα
       
FERb 033    
ERβ, EC50: 4.8 nM
ERβ, Ki: 7.1 nM
     
ERα degrader 9  
ERα
       
Kaempferol (Standard)  
ERα
       
Estrogen receptor antagonist 8
Estrogen receptor
         
(±)-8-Prenylnaringenin  
ERα, IC50: 57 nM
ERβ, IC50: 68 nM
     
PROTAC ERα Degrader-9  
ERα, Ki: 0.25 μM
ERβ, Ki: >79 μM
     
CHF 4227 free base  
hERα, Ki: 0.017 nM
hERβ, Ki: 0.099 nM
     
CMP8  
MGERα, IC50: 29 nM
MGRERα, IC50: 41 nM
hERα, IC50: 1100 nM
hERβ, IC50: 2200 nM
     
PROTAC ERα Degrader-7  
ERα, DC50: 0.000006 μM
       
LX-039
Estrogen receptor, EC50: 2.29 nM
         
rel-Erteberel    
ERβ, IC50: 1.54 nM
ERβ, EC50: 3.61 nM
     
ER degrader 6  
ERα
       
ERRα antagonist-2      
ERRα, IC50: 0.80 μM
   
SR19881        
ERRβ, EC50: 0.63 μM
ERRγ, EC50: 0.39 μM
(+)-Medicarpin    
ERβ
     
ERRγ inverse agonist 2          
ERRγ, Kd: 6.5 μM
ERα degrader 10  
ERα, IC50: 24 nM
       
7β-Hydroxy-epi-androsterone    
ERβ
     
(1S,3R)-GNE-502  
ERα, EC50: 13 nM
       
Estrogen receptor-IN-1  
ERα, IC50: 13 μM
ERβ, IC50: 5 μM
     
PSDalpha  
ERα
       
Estrogen receptor modulator 6  
ERα, Ki: 8.4 nM
ERβ, Ki: 0.44 nM
     
PROTAC ER Degrader-11
ER
         
(R)-DPN  
ERα, EC50: 2.9 nM
ERβ, EC50: 0.8 nM
     
LSD1/ER-IN-1  
ERα
ERβ
     
Bisphenol C  
ERα